世界のオカリバ市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21JY00001)
◆英語タイトル:Global Ocaliva Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21JY00001
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年7月
◆ページ数:107
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥396,720見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥595,080見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥793,440見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、オカリバの世界市場を広く調査・分析し、今後の市場展望をまとめております。オカリバの種類別市場規模(5mg、10mg)、用途別市場規模(原発性胆汁性肝硬変、非アルコール性脂肪肝疾患、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Intercept Pharmaceuticals、Dainippon Sumitomo Pharma
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:5mg、10mg
・用途別分析2016年-2026年:原発性胆汁性肝硬変、非アルコール性脂肪肝疾患、その他
・オカリバの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・オカリバのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・オカリバのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・オカリバの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・オカリバの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Ocaliva market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Ocaliva size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Ocaliva market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Ocaliva market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
5mg
10mg

Market segment by Application can be divided into
Primary Biliary Cirrhosis
Nonalcoholic Fatty Liver Disease
Other

The key market players for global Ocaliva market are listed below:
Intercept Pharmaceuticals
Dainippon Sumitomo Pharma

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Ocaliva product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ocaliva, with price, sales, revenue and global market share of Ocaliva in 2018 and 2019.
Chapter 3, the Ocaliva competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ocaliva breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Ocaliva market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Ocaliva sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Ocaliva Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ocaliva Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 5mg
1.2.3 10mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Ocaliva Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Primary Biliary Cirrhosis
1.3.3 Nonalcoholic Fatty Liver Disease
1.3.4 Other
1.4 Global Ocaliva Market Size & Forecast
1.4.1 Global Ocaliva Sales in Value (2016-2026))
1.4.2 Global Ocaliva Sales in Volume (2016-2026)
1.4.3 Global Ocaliva Price by Type (2016-2026) & (USD/Unit)
1.5 Global Ocaliva Production Capacity Analysis
1.5.1 Global Ocaliva Total Production Capacity (2016-2026)
1.5.2 Global Ocaliva Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Ocaliva Market Drivers
1.6.2 Ocaliva Market Restraints
1.6.3 Ocaliva Trends Analysis
2 Manufacturers Profiles
2.1 Intercept Pharmaceuticals
2.1.1 Intercept Pharmaceuticals Details
2.1.2 Intercept Pharmaceuticals Major Business
2.1.3 Intercept Pharmaceuticals Ocaliva Product and Services
2.1.4 Intercept Pharmaceuticals Ocaliva Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Dainippon Sumitomo Pharma
2.2.1 Dainippon Sumitomo Pharma Details
2.2.2 Dainippon Sumitomo Pharma Major Business
2.2.3 Dainippon Sumitomo Pharma Ocaliva Product and Services
2.2.4 Dainippon Sumitomo Pharma Ocaliva Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Ocaliva Sales by Manufacturer
3.1 Global Ocaliva Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Ocaliva Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Ocaliva
3.4 Market Concentration Rate
3.4.1 Top 3 Ocaliva Manufacturer Market Share
3.4.2 Top 6 Ocaliva Manufacturer Market Share
3.5 Global Ocaliva Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Ocaliva Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Ocaliva Market Size by Region
4.1.1 Global Ocaliva Sales in Volume by Region (2016-2026)
4.1.2 Global Ocaliva Revenue by Region (2016-2026)
4.2 North America Ocaliva Revenue (2016-2026)
4.3 Europe Ocaliva Revenue (2016-2026)
4.4 Asia-Pacific Ocaliva Revenue (2016-2026)
4.5 South America Ocaliva Revenue (2016-2026)
4.6 Middle East and Africa Ocaliva Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Ocaliva Sales in Volume by Type (2016-2026)
5.2 Global Ocaliva Revenue by Type (2016-2026)
5.3 Global Ocaliva Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Ocaliva Sales in Volume by Application (2016-2026)
6.2 Global Ocaliva Revenue by Application (2016-2026)
6.3 Global Ocaliva Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Ocaliva Sales by Type (2016-2026)
7.2 North America Ocaliva Sales by Application (2016-2026)
7.3 North America Ocaliva Market Size by Country
7.3.1 North America Ocaliva Sales in Volume by Country (2016-2026)
7.3.2 North America Ocaliva Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Ocaliva Sales by Type (2016-2026)
8.2 Europe Ocaliva Sales by Application (2016-2026)
8.3 Europe Ocaliva Market Size by Country
8.3.1 Europe Ocaliva Sales in Volume by Country (2016-2026)
8.3.2 Europe Ocaliva Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Ocaliva Sales by Type (2016-2026)
9.2 Asia-Pacific Ocaliva Sales by Application (2016-2026)
9.3 Asia-Pacific Ocaliva Market Size by Region
9.3.1 Asia-Pacific Ocaliva Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Ocaliva Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Ocaliva Sales by Type (2016-2026)
10.2 South America Ocaliva Sales by Application (2016-2026)
10.3 South America Ocaliva Market Size by Country
10.3.1 South America Ocaliva Sales in Volume by Country (2016-2026)
10.3.2 South America Ocaliva Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Ocaliva Sales by Type (2016-2026)
11.2 Middle East & Africa Ocaliva Sales by Application (2016-2026)
11.3 Middle East & Africa Ocaliva Market Size by Country
11.3.1 Middle East & Africa Ocaliva Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Ocaliva Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Ocaliva Typical Distributors
12.3 Ocaliva Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Ocaliva Revenue by Type, (USD Million), 2021-2026
Table 2. Global Ocaliva Revenue by Application, (USD Million), 2021-2026
Table 3. Intercept Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Intercept Pharmaceuticals Major Business
Table 5. Intercept Pharmaceuticals Ocaliva Product and Services
Table 6. Intercept Pharmaceuticals Ocaliva Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Dainippon Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Dainippon Sumitomo Pharma Major Business
Table 9. Dainippon Sumitomo Pharma Ocaliva Product and Services
Table 10. Dainippon Sumitomo Pharma Ocaliva Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Global Ocaliva Sales by Manufacturer (2019-2021e) & (K Units)
Table 12. Global Ocaliva Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 13. Market Position of Manufacturers in Ocaliva, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 14. Global Ocaliva Production Capacity by Company, (K Units): 2020 VS 2021
Table 15. Head Office and Ocaliva Production Site of Key Manufacturer
Table 16. Ocaliva New Entrant and Capacity Expansion Plans
Table 17. Ocaliva Mergers & Acquisitions in the Past Five Years
Table 18. Global Ocaliva Sales by Region (2016-2021e) & (K Units)
Table 19. Global Ocaliva Sales by Region (2021-2026) & (K Units)
Table 20. Global Ocaliva Revenue by Region (2016-2021e) & (USD Million)
Table 21. Global Ocaliva Revenue by Region (2021-2026) & (USD Million)
Table 22. Global Ocaliva Sales by Type (2016-2021e) & (K Units)
Table 23. Global Ocaliva Sales by Type (2021-2026) & (K Units)
Table 24. Global Ocaliva Revenue by Type (2016-2021e) & (USD Million)
Table 25. Global Ocaliva Revenue by Type (2021-2026) & (USD Million)
Table 26. Global Ocaliva Price by Type (2016-2021e) & (USD/Unit)
Table 27. Global Ocaliva Price by Type (2021-2026) & (USD/Unit)
Table 28. Global Ocaliva Sales by Application (2016-2021e) & (K Units)
Table 29. Global Ocaliva Sales by Application (2021-2026) & (K Units)
Table 30. Global Ocaliva Revenue by Application (2016-2021e) & (USD Million)
Table 31. Global Ocaliva Revenue by Application (2021-2026) & (USD Million)
Table 32. Global Ocaliva Price by Application (2016-2021e) & (USD/Unit)
Table 33. Global Ocaliva Price by Application (2021-2026) & (USD/Unit)
Table 34. North America Ocaliva Sales by Country (2016-2021e) & (K Units)
Table 35. North America Ocaliva Sales by Country (2021-2026) & (K Units)
Table 36. North America Ocaliva Revenue by Country (2016-2021e) & (USD Million)
Table 37. North America Ocaliva Revenue by Country (2021-2026) & (USD Million)
Table 38. North America Ocaliva Sales by Type (2016-2021e) & (K Units)
Table 39. North America Ocaliva Sales by Type (2021-2026) & (K Units)
Table 40. North America Ocaliva Sales by Application (2016-2021e) & (K Units)
Table 41. North America Ocaliva Sales by Application (2021-2026) & (K Units)
Table 42. Europe Ocaliva Sales by Country (2016-2021e) & (K Units)
Table 43. Europe Ocaliva Sales by Country (2021-2026) & (K Units)
Table 44. Europe Ocaliva Revenue by Country (2016-2021e) & (USD Million)
Table 45. Europe Ocaliva Revenue by Country (2021-2026) & (USD Million)
Table 46. Europe Ocaliva Sales by Type (2016-2021e) & (K Units)
Table 47. Europe Ocaliva Sales by Type (2021-2026) & (K Units)
Table 48. Europe Ocaliva Sales by Application (2016-2021e) & (K Units)
Table 49. Europe Ocaliva Sales by Application (2021-2026) & (K Units)
Table 50. Asia-Pacific Ocaliva Sales by Region (2016-2021e) & (K Units)
Table 51. Asia-Pacific Ocaliva Sales by Region (2021-2026) & (K Units)
Table 52. Asia-Pacific Ocaliva Revenue by Region (2016-2021e) & (USD Million)
Table 53. Asia-Pacific Ocaliva Revenue by Region (2021-2026) & (USD Million)
Table 54. Asia-Pacific Ocaliva Sales by Type (2016-2021e) & (K Units)
Table 55. Asia-Pacific Ocaliva Sales by Type (2021-2026) & (K Units)
Table 56. Asia-Pacific Ocaliva Sales by Application (2016-2021e) & (K Units)
Table 57. Asia-Pacific Ocaliva Sales by Application (2021-2026) & (K Units)
Table 58. South America Ocaliva Sales by Country (2016-2021e) & (K Units)
Table 59. South America Ocaliva Sales by Country (2021-2026) & (K Units)
Table 60. South America Ocaliva Revenue by Country (2016-2021e) & (USD Million)
Table 61. South America Ocaliva Revenue by Country (2021-2026) & (USD Million)
Table 62. South America Ocaliva Sales by Type (2016-2021e) & (K Units)
Table 63. South America Ocaliva Sales by Type (2021-2026) & (K Units)
Table 64. South America Ocaliva Sales by Application (2016-2021e) & (K Units)
Table 65. South America Ocaliva Sales by Application (2021-2026) & (K Units)
Table 66. Middle East & Africa Ocaliva Sales by Country (2016-2021e) & (K Units)
Table 67. Middle East & Africa Ocaliva Sales by Country (2021-2026) & (K Units)
Table 68. Middle East & Africa Ocaliva Revenue by Country (2016-2021e) & (USD Million)
Table 69. Middle East & Africa Ocaliva Revenue by Country (2021-2026) & (USD Million)
Table 70. Middle East & Africa Ocaliva Sales by Type (2016-2021e) & (K Units)
Table 71. Middle East & Africa Ocaliva Sales by Type (2021-2026) & (K Units)
Table 72. Middle East & Africa Ocaliva Sales by Application (2016-2021e) & (K Units)
Table 73. Middle East & Africa Ocaliva Sales by Application (2021-2026) & (K Units)
Table 74. Direct Channel Pros & Cons
Table 75. Indirect Channel Pros & Cons
Table 76. Ocaliva Typical Distributors
Table 77. Ocaliva Typical Customers
List of Figures
Figure 1. Ocaliva Picture
Figure 2. Global Ocaliva Sales Market Share by Type in 2020
Figure 3. 5mg
Figure 4. 10mg
Figure 5. Global Ocaliva Sales Market Share by Application in 2020
Figure 6. Primary Biliary Cirrhosis
Figure 7. Nonalcoholic Fatty Liver Disease
Figure 8. Other
Figure 9. Global Ocaliva Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Ocaliva Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Ocaliva Sales (2016-2026) & (K Units)
Figure 12. Global Ocaliva Price by Type (2016-2026) & (USD/Unit)
Figure 13. Global Ocaliva Production Capacity (2016-2026) & (K Units)
Figure 14. Global Ocaliva Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Ocaliva Market Drivers
Figure 16. Ocaliva Market Restraints
Figure 17. Ocaliva Market Trends
Figure 18. Global Ocaliva Sales Market Share by Manufacturer in 2020
Figure 19. Global Ocaliva Revenue Market Share by Manufacturer in 2020
Figure 20. Ocaliva Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Ocaliva Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Ocaliva Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Ocaliva Sales Market Share by Region (2016-2026)
Figure 24. Global Ocaliva Revenue Market Share by Region (2016-2026)
Figure 25. North America Ocaliva Revenue (2016-2026) & (USD Million)
Figure 26. Europe Ocaliva Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Ocaliva Revenue (2016-2026) & (USD Million)
Figure 28. South America Ocaliva Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Ocaliva Revenue (2016-2026) & (USD Million)
Figure 30. Global Ocaliva Sales Market Share by Type (2016-2026)
Figure 31. Global Ocaliva Revenue Market Share by Type (2016-2026)
Figure 32. Global Ocaliva Price by Type (2016-2026) & (USD/Unit)
Figure 33. Global Ocaliva Sales Market Share by Application (2016-2026)
Figure 34. Global Ocaliva Revenue Market Share by Application (2016-2026)
Figure 35. Global Ocaliva Price by Application (2016-2026) & (USD/Unit)
Figure 36. North America Ocaliva Sales Market Share by Type (2016-2026)
Figure 37. North America Ocaliva Sales Market Share by Application (2016-2026)
Figure 38. North America Ocaliva Sales Market Share by Country (2016-2026)
Figure 39. North America Ocaliva Revenue Market Share by Country (2016-2026)
Figure 40. United States Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Ocaliva Sales Market Share by Type (2016-2026)
Figure 44. Europe Ocaliva Sales Market Share by Application (2016-2026)
Figure 45. Europe Ocaliva Sales Market Share by Country (2016-2026)
Figure 46. Europe Ocaliva Revenue Market Share by Country (2016-2026)
Figure 47. Germany Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Ocaliva Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Ocaliva Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Ocaliva Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Ocaliva Revenue Market Share by Region (2016-2026)
Figure 56. China Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Ocaliva Sales Market Share by Type (2016-2026)
Figure 63. South America Ocaliva Sales Market Share by Application (2016-2026)
Figure 64. South America Ocaliva Sales Market Share by Country (2016-2026)
Figure 65. South America Ocaliva Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Ocaliva Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Ocaliva Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Ocaliva Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Ocaliva Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Ocaliva Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source


【掲載企業】

Intercept Pharmaceuticals、Dainippon Sumitomo Pharma

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のオカリバ市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Ocaliva Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。